HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin).

Abstract
We used dDAVP, the 1-desamino-8-D arginine analogue of arginine vasopressin with high antidiuretic and low vasopressor potency, to treat 29 patients with neurogenic diabetes insipidus for up to 22 months. Intranasal dDAVP, 2.5 to 15 microgram twice daily, provided excellent control in most patients. Individual responses were independent of age, weight, and severity of diabetes insipidus. Resistance to dDAVP may be a rare complication of prolonged therapy. Two patients with acute postoperative diabetes insipidus were effectively treated with 5 microgram of dDAVP every 14 to 18 h. Compared to previous therapy, side effects of dDAVP were minimal (headaches in two patients), and control of symptoms and urine volume was as good as with vasopressin tannate in oil or better than chlorpropamide and lysine vasopressin nasal spray. We conclude that intranasal dDAVP, because of efficacy, long duration of action, and infrequent side effects, is the preferred treatment of neurogenic diabetes insipidus in children and adults.
AuthorsW E Cobb, S Spare, S Reichlin
JournalAnnals of internal medicine (Ann Intern Med) Vol. 88 Issue 2 Pg. 183-8 (Feb 1978) ISSN: 0003-4819 [Print] United States
PMID626447 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Vasopressins
  • Arginine Vasopressin
Topics
  • Adolescent
  • Adult
  • Aged
  • Arginine Vasopressin (analogs & derivatives, therapeutic use)
  • Child
  • Diabetes Insipidus (drug therapy, etiology, urine)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nervous System Diseases (complications)
  • Osmolar Concentration
  • Postoperative Complications
  • Vasopressins (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: